A share price of Qiagen NV [QGEN] is currently trading at $39.88, up 3.45%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The QGEN shares have gain 3.85% over the last week, with a monthly amount drifted -8.03%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Qiagen NV [NYSE: QGEN] stock has seen the most recent analyst activity on February 19, 2025, when Robert W. Baird downgraded its rating to a Neutral and also revised its price target to $42 from $52. Previously, Morgan Stanley downgraded its rating to Equal-Weight on January 06, 2025, and kept the price target unchanged to $48. On December 10, 2024, upgrade upgraded it’s rating to Buy and revised its price target to $54 on the stock. HSBC Securities downgraded its rating to a Hold but stick to its price target of $49 on October 17, 2024. Wolfe Research upgraded its rating to a Outperform but $50 remained the price target by the analyst firm on June 27, 2024. Wells Fargo started tracking with a Equal Weight rating for this stock on December 19, 2023, and assigned it a price target of $44. In a note dated December 13, 2023, Wolfe Research initiated an Peer Perform rating.
Qiagen NV experienced fluctuations in its stock price throughout the past year between $37.63 and $47.92. Currently, Wall Street analysts expect the stock to reach $49 within the next 12 months. Qiagen NV [NYSE: QGEN] shares were valued at $39.88 at the most recent close of the market. An investor can expect a potential return of 22.87% based on the average QGEN price forecast.
Analyzing the QGEN fundamentals
Trailing Twelve Months sales for Qiagen NV [NYSE:QGEN] were 1.98B which represents 2.36% growth. Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at 0.05%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.04%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.02 and Total Capital is 0.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.39.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 39.14 points at the first support level, and at 38.41 for the second support level. However, for the 1st resistance point, the stock is sitting at 40.37, and for the 2nd resistance point, it is at 40.87.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Qiagen NV [NYSE:QGEN] is 3.61. Further, the Quick Ratio stands at 3.09, while the Cash Ratio is 1.22. Considering the valuation of this stock, the price to sales ratio is 4.39, the price to book ratio is 2.42 and price to earnings (TTM) ratio is 107.35.
Transactions by insiders
Recent insider trading involved Sackers Roland, Officer, that happened on Sep 11 ’24 when 25000.0 shares were purchased.
